Protective effects of PPARγ agonist in glomerulosclerosis rats induced by adriamycin.
Tian-Biao
TB
Zhou
Chao
C
Ou
Cheng-Piao
CP
Luo
Hui-Ling
HL
Xu
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000633:toxicity; D004317:Doxorubicin / Q000633:toxicity; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D047495:PPAR gamma / Q000819:agonists*; D000077205:Pioglitazone; D051381:Rats; D045162:Thiazolidinediones / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D007004:Hypoglycemic Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; D004317:Doxorubicin; D000077205:Pioglitazone